<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using inverse polymerase chain reaction, we identified CD44, located on chromosome 11p13, as a novel translocation partner of IGH in 9 of 114 cases of gastric, nongastric extranodal, follicular, and nodal diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Notably, these translocations involving IGHSmu were detected in follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and exclusively in germinal center B cell-ike (GCB)-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>CD44 is not expressed in reactive GC B cells </plain></SENT>
<SENT sid="3" pm="."><plain>The IGHSmu/CD44 translocations substitute Smu for the CD44 promoter and remove exon 1 of CD44, resulting in the overexpression of <z:e sem="disease" ids="C0270602" disease_type="Mental or Behavioral Dysfunction" abbrv="">Imu</z:e>-CD44 hybrid <z:chebi fb="2" ids="33699">mRNA</z:chebi> transcripts activated from derivative 11 that encode a new CD44 variant lacking the leader <z:chebi fb="7" ids="16670">peptide</z:chebi> and with a unique C-terminus (CD44DeltaEx1) </plain></SENT>
<SENT sid="4" pm="."><plain>When overexpressed in vitro in the CD44(-) <z:e sem="disease" ids="C1333295" disease_type="Neoplastic Process" abbrv="">GCB-DLBCL</z:e> cell line BJAB, CD44DeltaEx1-green fluorescent protein localized to the cytoplasm and nucleus, whereas CD44s-green fluorescent protein (standard form) localized to the plasma membrane </plain></SENT>
<SENT sid="5" pm="."><plain>The ectopic expression of CD44DeltaEx1 in BJAB cells enhanced their proliferation rate and clonogenic ability, indicating a possible pathogenic role of the translocation </plain></SENT>
</text></document>